[ad_1]
Vivici was incorporated in December 2022 to bring animal-free dairy proteins to market, and in March 2023 the company hired Stephan van Sint Fiet as CEO, who joined from IFF where he led the Dairy Cultures & Food Enzymes business unit, building on the experience gained in the food enzymes business at Novozymes. Stephan previously helped scale two start-ups: Evolva, a company producing high-value natural products through fermentation, and Biognosys, an advanced proteomics company.
Pieter Wolters, MD of dsm-firmenich Venturing, comments: “We are thrilled to be a founding investor in Vivici BV’s Series Seed capital raise. Vivici has the foundation for success, and builds on multiple years of joint technology and application development, and is now well-positioned as an agile startup company.”
Stephan van Sint Fiet, CEO of Vivici, states: “I’m thrilled to work with such an experienced team, that knows what it takes to not only develop, but manufacture, register and commercialize great ingredients. Together, we will build Vivici into a precision fermentation leader that contributes to a future-proof food system.“
Learn more about Vivici at www.vivici.com
[ad_2]
Source link